Cargando…

p65BTK Is a Novel Biomarker and Therapeutic Target in Solid Tumors

Bruton’s tyrosine kinase (BTK) is a non-receptor intracellular kinase playing a key role in the proliferation and survival of normal and malignant B-lymphocytes. Its targeting by Ibrutinib, the first specific inhibitor, represented a turning point for the therapy of certain types of B-cell leukemias...

Descripción completa

Detalles Bibliográficos
Autores principales:	Grassilli, Emanuela, Cerrito, Maria Grazia, Bonomo, Sara, Giovannoni, Roberto, Conconi, Donatella, Lavitrano, Marialuisa
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Cell and Developmental Biology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8215537/ https://www.ncbi.nlm.nih.gov/pubmed/34164404 http://dx.doi.org/10.3389/fcell.2021.690365

Ejemplares similares

BTK, the new kid on the (oncology) block?
por: Grassilli, Emanuela, et al.
Publicado: (2022)

p65BTK is a novel potential actionable target in KRAS-mutated/EGFR-wild type lung adenocarcinoma
por: Giordano, Federica, et al.
Publicado: (2019)

Specific Expression of a New Bruton Tyrosine Kinase Isoform (p65BTK) in the Glioblastoma Gemistocytic Histotype
por: Sala, Luca, et al.
Publicado: (2019)

GSK3A Is Redundant with GSK3B in Modulating Drug Resistance and Chemotherapy-Induced Necroptosis
por: Grassilli, Emanuela, et al.
Publicado: (2014)

Targeting Solid Tumors With BTK Inhibitors
por: Uckun, Fatih M., et al.
Publicado: (2021)

Unexpected frequency of genomic alterations in histologically normal colonic tissue from colon cancer patients
por: Conconi, Donatella, et al.
Publicado: (2016)

Reining in BTK: Interdomain Interactions and Their Importance in the Regulatory Control of BTK
por: Kueffer, Lauren E., et al.
Publicado: (2021)

Targeting the NLRP3 Inflammasome via BTK
por: Weber, Alexander N. R.
Publicado: (2021)

Comparative Analysis of BTK Inhibitors and Mechanisms Underlying Adverse Effects
por: Estupiñán, H. Yesid, et al.
Publicado: (2021)

Metronomic combination of Vinorelbine and 5Fluorouracil is able to inhibit triple-negative breast cancer cells. Results from the proof-of-concept VICTOR-0 study
por: Cerrito, Maria Grazia, et al.
Publicado: (2018)

Differential Requirement of Vav Proteins for Btk-dependent and –Independent Signaling During B Cell Development
por: Betzler, Annika C., et al.
Publicado: (2022)

A novel oncogenic BTK isoform is overexpressed in colon cancers and required for RAS-mediated transformation
por: Grassilli, E, et al.
Publicado: (2016)

Editorial: Targeting Bruton Tyrosine Kinase
por: Brunner, Cornelia, et al.
Publicado: (2022)

Multifaceted Immunomodulatory Effects of the BTK Inhibitors Ibrutinib and Acalabrutinib on Different Immune Cell Subsets – Beyond B Lymphocytes
por: Zhu, Sining, et al.
Publicado: (2021)

Bruton’s Tyrosine Kinase (BTK) Inhibitor RN486 Overcomes ABCB1-Mediated Multidrug Resistance in Cancer Cells
por: Dong, Xing-Duo, et al.
Publicado: (2020)

BTK Isoforms p80 and p65 Are Expressed in Head and Neck Squamous Cell Carcinoma (HNSCC) and Involved in Tumor Progression
por: Betzler, Annika C., et al.
Publicado: (2023)

Patient-Derived Induced Pluripotent Stem Cells (iPSCs) and Cerebral Organoids for Drug Screening and Development in Autism Spectrum Disorder: Opportunities and Challenges
por: Villa, Chiara, et al.
Publicado: (2021)

Using Copy Number Alterations to Identify New Therapeutic Targets for Bladder Carcinoma
por: Conconi, Donatella, et al.
Publicado: (2016)

AhRR and PPP1R3C: Potential Prognostic Biomarkers for Serous Ovarian Cancer
por: Ardizzoia, Alessandra, et al.
Publicado: (2023)

Editorial: Biomarkers and therapeutic strategies in acute lymphoblastic leukemia
por: Lee, Ki-Young, et al.
Publicado: (2023)

Identification of Prognostic Biomarkers for Multiple Solid Tumors Using a Human Villi Development Model
por: Zhang, Botao, et al.
Publicado: (2020)

Influence of Bruton’s Tyrosine Kinase (BTK) on Epithelial–Mesenchymal Transition (EMT) Processes and Cancer Stem Cell (CSC) Enrichment in Head and Neck Squamous Cell Carcinoma (HNSCC)
por: Leichtle, Franziska, et al.
Publicado: (2023)

Protein Tyrosine Phosphatases in Neuroblastoma: Emerging Roles as Biomarkers and Therapeutic Targets
por: Nunes-Xavier, Caroline E., et al.
Publicado: (2021)

Identification and characterization of putative biomarkers and therapeutic axis in Glioblastoma multiforme microenvironment
por: Kumari, Smita, et al.
Publicado: (2023)

BRG1 Activates PR65A Transcription to Regulate NO Bioavailability in Vascular Endothelial Cells
por: Chen, Baoyu, et al.
Publicado: (2020)

The Roles of CircRNAs in Bladder Cancer: Biomarkers, Tumorigenesis Drivers, and Therapeutic Targets
por: Cheng, Fajuan, et al.
Publicado: (2021)

Role of Extracellular Vesicles as Potential Diagnostic and/or Therapeutic Biomarkers in Chronic Cardiovascular Diseases
por: Martin-Ventura, Jose Luis, et al.
Publicado: (2022)

The Roles of lncRNA in Myocardial Infarction: Molecular Mechanisms, Diagnosis Biomarkers, and Therapeutic Perspectives
por: Xie, Luhan, et al.
Publicado: (2021)

A Comprehensive Overview of circRNAs: Emerging Biomarkers and Potential Therapeutics in Gynecological Cancers
por: Ma, Yalan, et al.
Publicado: (2021)

LncRNA GACAT3: A Promising Biomarker and Therapeutic Target in Human Cancers
por: Yuan, Xin, et al.
Publicado: (2022)

A New World of Biomarkers and Therapeutics for Female Reproductive System and Breast Cancers: Circular RNAs
por: Tran, Anh M., et al.
Publicado: (2020)

S100A8/A9 in Myocardial Infarction: A Promising Biomarker and Therapeutic Target
por: Cai, ZhuLan, et al.
Publicado: (2020)

ALKBH1-8 and FTO: Potential Therapeutic Targets and Prognostic Biomarkers in Lung Adenocarcinoma Pathogenesis
por: Wu, Geting, et al.
Publicado: (2021)

Comprehensive analysis to identify the neurotransmitter receptor-related genes as prognostic and therapeutic biomarkers in hepatocellular carcinoma
por: Wang, Xiaoqiang, et al.
Publicado: (2022)

Comprehensive Analysis and Identification of Prognostic Biomarkers and Therapeutic Targets Among FAM83 Family Members for Gastric Cancer
por: Zhang, Tianhao, et al.
Publicado: (2021)

miRNA-7062-5p Promoting Bone Resorption After Bone Metastasis of Colorectal Cancer Through Inhibiting GPR65
por: Chen, Liang, et al.
Publicado: (2021)

MCM4 Is a Novel Biomarker Associated With Genomic Instability, BRCAness Phenotype, and Therapeutic Potentials in Soft-Tissue Sarcoma
por: Liu, Qi, et al.
Publicado: (2021)

Identification of Therapeutic Targets and Prognostic Biomarkers Among Chemokine (C-C Motif) Ligands in the Liver Hepatocellular Carcinoma Microenvironment
por: Jiang, Zhongyi, et al.
Publicado: (2021)

H3 histone methylation landscape in male urogenital cancers: from molecular mechanisms to epigenetic biomarkers and therapeutic targets
por: Burlibasa, Liliana, et al.
Publicado: (2023)

HDAC8: A Promising Therapeutic Target for Acute Myeloid Leukemia
por: Spreafico, Marco, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_p8mjmsqu8i6c8sj47nfllasa8r